Ginkgo Bioworks Holdings, Inc.
DNA
DELAYED 1 MONTH

4 insider filings · Latest: Jul 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 22, 2026May 26 9:04 PMSteven P. CoenChief Financial Officer
Sale
307$8.33$2.6K50,704(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 28, 2026Jul 30 8:28 PMBarry Canton10% Owner
Grant/Award
319,332—127,423(I)

View →

Jul 28, 2026Jul 30 8:27 PMReshma P. ShettyDirector, President & Founder, 10% Owner
Grant/Award
319,332—117,135(I)

View →

Jul 28, 2026Jul 30 8:26 PMJason R KellyDirector, Chief Executive Officer & Founder
Grant/Award
383,725—309,467(D)

View →

May 21, 2026May 26 9:04 PMSteven P. CoenChief Financial Officer
Option Exercise
743—3,443(D)

View →